This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Red Hat, Celgene: Analysts' New Ratings

Stocks in this article: BIIB CELG CHK CIEN CLS RHT S TLAB URS

Editor's Note: Green and red arrows refer to intraday stock price movement.


Biogen Idec (BIIB) upgraded at RBC from Sector Perform to Outperform, RBC Capital said. $75 price target. New analyst expects Tysabri to perform above consensus expectations.

Celgene (CELG) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $55 price target. Valuation call, as the stock is already pricing in solid 2011 growth.

Chesapeake Energy (CHK) upgraded at Canaccord from Hold to Buy, Canaccord Genuity said. $49 price target. Company is improving capital productivity and realizing higher gas prices.

Ciena (CIEN) rated new Outperform at Wells Fargo. Company is leveraged to a multi-year optical upgrade cycle.

Celestica (CLS) upgraded at Collins Stewart from Neutral to Buy, Collins Stewart said. $15 price target. Company is turning its business around and winning new customers.

Flextronics (FLEX) upgraded at Collins Stewart from Neutral to Buy, Collins Stewart said. $11 price target. Company can deliver double-digit growth in each of the next two years.

Fluor (FLR) upgraded at BMO from Underperform to Market Perform, BMO Capital said. $66 price target. Company has a solid balance sheet, and can absorb losses from two fixed-price contracts. (NTES) upgraded at Brean Murray from Hold to Buy, Brean Murray said. $54 price target. Company is seeing higher demand across the board.

Ormat Technologies (ORA) downgraded at Baird to Neutral from Outperform, Robert Baird said. $24 price target. Company lowered its guidance, because of rising costs.

Oracle (ORCL) rated new Hold at ThinkEquity. $35 price target. Stock is already pricing in solid near-term growth.

Quanta Services (PWR) downgraded at Deutsche Bank to Hold. $22 price target. Valuation call, as the stock is up 26% over the past three months.

Regeneron Pharmaceuticals (REGN) upgraded at RBC from Sector Perform to Outperform, RBC Capital said. $48 price target. Company continues to price solid clinical data.

Red Hat (RHT) downgraded at JP Morgan from Neutral to Underweight. $32 price target. Valuation call, as the stock is already pricing in healthy free cash flow growth.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs